| A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing WW Zhang, S Karmakar, S Gannavaram, R Dey, P Lypaczewski, N Ismail, ... Nature Communications 11 (1), 3461, 2020 | 96 | 2020 |
| Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, ... PLoS neglected tropical diseases 7 (4), e2174, 2013 | 75 | 2013 |
| Live vaccination tactics: possible approaches for controlling visceral leishmaniasis N Saljoughian, T Taheri, S Rafati Frontiers in immunology 5, 134, 2014 | 68 | 2014 |
| Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells S Varikuti, B Singh, G Volpedo, DK Ahirwar, BK Jha, N Saljoughian, ... British Journal of Cancer 122 (7), 1005-1013, 2020 | 65 | 2020 |
| Cationic solid–lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice N Saljoughian, F Zahedifard, D Doroud, F Doustdari, M Vasei, ... Parasite Immunology 35 (12), 397-408, 2013 | 59 | 2013 |
| Development and evaluation of controlled-release buccoadhesive verapamil hydrochloride tablets J Emami, J Varshosaz, N Saljoughian DARU Journal of Pharmaceutical Sciences 16 (2), 60-69, 2008 | 51 | 2008 |
| Cutting edge: CXCR3 escapes X chromosome inactivation in T cells during infection: potential implications for sex differences in immune responses S Oghumu, S Varikuti, JC Stock, G Volpedo, N Saljoughian, CA Terrazas, ... The Journal of Immunology 203 (4), 789-794, 2019 | 49 | 2019 |
| Design of mannosylated oral amphotericin B nanoformulation: Efficacy and safety in visceral leishmaniasis HS Sarwar, MF Sohail, N Saljoughian, AU Rehman, S Akhtar, A Nadhman, ... Artificial cells, nanomedicine, and biotechnology 46 (sup1), 521-531, 2018 | 35 | 2018 |
| Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis M Shahbazi, F Zahedifard, N Saljoughian, D Doroud, S Jamshidi, ... Veterinary parasitology 212 (3-4), 130-139, 2015 | 33 | 2015 |
| Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by … S Varikuti, S Oghumu, N Saljoughian, MS Pioso, BE Sedmak, ... Acta tropica 173, 102-108, 2017 | 27 | 2017 |
| The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani S Varikuti, G Volpedo, N Saljoughian, OM Hamza, G Halsey, NM Ryan, ... The Journal of infectious diseases 219 (4), 599-608, 2019 | 25 | 2019 |
| Leishmania tarentolae expressing CXCL‐10 as an efficient immunotherapy approach against Leishmania major‐infected BALB/c mice H Montakhab‐Yeganeh, Z Abdossamadi, F Zahedifard, Y Taslimi, ... Parasite Immunology 39 (10), e12461, 2017 | 24 | 2017 |
| Aging influences the cardiac macrophage phenotype and function during steady state and during inflammation NS Esfahani, Q Wu, N Kumar, LP Ganesan, WP Lafuse, MVS Rajaram Aging Cell 20 (8), e13438, 2021 | 23 | 2021 |
| CRISPR gene editing of human primary NK and T cells for cancer immunotherapy E Elmas, N Saljoughian, M de Souza Fernandes Pereira, BP Tullius, ... Frontiers in Oncology 12, 834002, 2022 | 16 | 2022 |
| Pentalinonsterol, a Constituent of Pentalinon andrieuxii, Possesses Potent Immunomodulatory Activity and Primes T Cell Immune Responses S Oghumu, S Varikuti, N Saljoughian, C Terrazas, AC Huntsman, ... Journal of natural products 80 (9), 2515-2523, 2017 | 15 | 2017 |
| Namvar Asl N, Papadopoulou B, Rafati S. Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine … N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, ... PLoS Negl Trop Dis 7 (4), e2174, 2013 | 9 | 2013 |
| A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nat Commun 11: 3461 WW Zhang, S Karmakar, S Gannavaram, R Dey, P Lypaczewski, N Ismail, ... | 7 | 2020 |
| Effect of Mycobacterium tuberculosis Enhancement of Macrophage P-Glycoprotein Expression and Activity on Intracellular Survival During Antituberculosis Drug … Q Wu, A Hossfeld, A Gerberick, N Saljoughian, C Tiwari, S Mehra, ... The Journal of infectious diseases 220 (12), 1989-1998, 2019 | 6 | 2019 |
| Comparison of protective potency of DNA and live vaccines expressing A2-CPA-CPB-CTE antigens against visceral leishmaniasis in Syrian hamster as preliminary study Y Taslimi, F Zahedifard, T Taheri, D Doroud, SL Dizaji, N Saljoughian, ... Iranian Journal of Parasitology 15 (3), 383, 2020 | 4 | 2020 |
| Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes Q Wu, N Kumar, WP Lafuse, OS Ahumada, N Saljoughian, E Whetstone, ... Iscience 25 (12), 2022 | 2 | 2022 |
